It’s tough to increase the bottom line at 15 percent annually for a decade, but that’s what Biomet has done. In addition, it looks as though long-term earnings growth of 15.7 percent is right in line with long-term sales growth of 15.8 percent, which means Biomet probably hasn’t had to play any accounting games to generate such solid results. The firm increased earnings the way a great company should—by selling more products, year in and year out.
